Presymptomatic Diagnosis of Neurofibromatosis 2

Abstract

The clinical spectrum of neurofibromatosis 2 (NF2) at the time of presymptomatic DNA diagnosis in at-risk first-degree relatives in five families were studied at the Cedars-Sinai Medical Center, UCLA School of Medicine, Los Angeles, and the Neurofibromatosis Institute, La Crescenta, CA.

Keywords

• neurofibromatosis 2
• presymptomatic
• vestibular schwannomas